ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,390, issued on Jan. 13, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).
"Dosage forms for Tyk2 inhibitors" was invented by Sherif Ibrahim Farag Badawy (Dayton, N.J.), Jonathan R. Brown (Chester, Great Britain), Candice Y. Choi (Palisades Park, N.J.), Christoph Gesenberg (Cheshire, Conn.), Vivienne Gray (Barnston, Great Britain), John Wynne Jones (Mwynglawdd, Great Britain), Umesh Kestur (North Brunswick, N.J.), Balvinder S. Vig (Milltown, N.J.), Xiaotian S. Yin (Kendall Park, N.J.), Christopher A. Zordan (East Brunswick, N.J.), Corey Bloom (Bend, Ore.) and Ian Yates (Bend, Ore.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Stable and bi...